The significant earnings miss likely pressures MNKD near term, but upcoming PDUFA catalysts (Afrezza pediatric, Furoscix ReadyFlow) may limit downside. Traders should monitor for any pre-approval signals and upcoming Phase 2 data for nintedanib DPI.
Price Chart
Executive Summary
MannKind reported Q1 2026 GAAP EPS of -$0.05, a 600% miss vs. consensus of $0.01, and revenue of $90.2M, 14.4% below the $105.3M estimate. The miss was driven by a 116% surge in SG&A from Furoscix expansion and R&D ramp-up, despite a 15% YoY revenue increase. Pipeline catalysts (Afrezza pediatric PDUFA May 29, Furoscix ReadyFlow PDUFA July 26) provide optionality but do not offset the earnings disappointment.
Key Financial Metrics
Key Facts
- GAAP EPS -$0.05 vs. consensus $0.01 (-600% miss)
- Revenue $90.2M vs. consensus $105.3M (-14.4% miss)
- YoY revenue growth 15% ($78.4M to $90.2M)
- SG&A expenses increased 116% to $54.1M
- Net loss $16.6M vs. net income $13.2M in Q1 2025
- Cash and investments $134M at quarter end
- Key upcoming PDUFA dates: Afrezza pediatric May 29, Furoscix ReadyFlow July 26
Financial Impact
Q1 EPS miss of $0.06 per share and revenue miss of $15.1M
Risk Factors
- Failed regulatory approvals for Afrezza pediatric or Furoscix ReadyFlow
- Continued elevated operating expenses without commensurate revenue growth
- Potential further dilution from debt settlements
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3289304 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 29, 2026 9w ago | Press Release | $3.85 $4.09 | ▲ +6.23% | ▲ +1.21% | $3.74 (−2.86%) |
Jul 24, 2026 9w ago | 8-K | $3.95 $4.07 | ▲ +3.04% | ▼ −0.26% | $3.74 (−5.32%) |
Jul 18, 2026 10w ago | Insider Cluster | $3.98 $3.90 | ▼ −2.01% | ▼ −6.13% | $3.74 (−6.03%) |
Jun 3, 2026 17w ago | Press Release | $3.36 $4.52 | ▲ +34.52% | ▲ +35.52% | $3.74 (+11.31%) |
Jun 2, 2026 17w ago | 8-K | $3.43 $4.05 | ▲ +18.08% | ▲ +19.64% | $3.74 (+9.04%) |
May 29, 2026 18w ago | Press Release | $3.77 $4.24 | ▲ +12.47% | ▲ +14.26% | $3.74 (−0.80%) |
May 29, 2026 18w ago | Press Release | $3.77 $4.24 | ▲ +12.47% | ▲ +14.26% | $3.74 (−0.80%) |
May 28, 2026 18w ago | 8-K | $3.64 $4.14 | ▲ +13.74% | ▲ +16.88% | $3.74 (+2.75%) |
May 27, 2026 18w ago | Press Release | $3.55 $3.93 | ▲ +10.70% | ▲ +12.61% | $3.74 (+5.35%) |
May 12, 2026 20w ago | Insider Cluster | $3.28 $3.63 | ▲ +10.67% | ▲ +12.40% | $3.74 (+14.02%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access